# The Misuse of Drugs Act 1971 (Modification) Order 2003, Article 2


(1) Schedule 2 to the Misuse of Drugs Act 1971 (which specifies the drugs which are subject to control under that Act) shall be amended as follows:
(2) In paragraph 1(a) of Part I of that Schedule there shall be inserted—
(a) after “Dihydrocodeinone O-carboxymethyloxime”, “Dihydroetorphine”; and
(b) after “Racemorphan”, “Remifentanil.”.
(3) In paragraph 1(a) of Part III of that Schedule, there shall be inserted—
(a) after “Haloxazolam”, “4-Hydroxy-n-butyric acid”; and
(b) after “N-Ethylamphetamine”, “Zolpidem”.
(4) In paragraph 1(b) of Part III of that Schedule, there shall be inserted—
(a) before “Atamestane”, “4-Androstene-3, 17-dione” and “5-Androstene-3, 17-diol”; and
(b) after “Nandrolone”, “19-Nor-4-Androstene-3, 17-dione”; and “19-Nor-5-Androstene-13, 17-diol”.

---
Source: https://www.legislation.gov.uk/ukdsi/2003/0110454901/article/2 (the official version)
Page: https://openlegislation.uk/draft-misuse-of-drugs-act-1971-modification-order-2003/article-2
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.